Hi Shombra, According to the ASX announcement on the 6th November 2023, there had been 34 patients dosed in the MAST trial.
Twenty five were available for their 42 day scan with seven pending results shortly.
I believe the MAST trial slowed down considerably on the purchase of Azer-cel and the urgency to get the OASIS trial into the clinic, money was being burned through at a rate of knots and as they were required to start OASIS at very small doses they did not want this to slow down due to financials.
Therefore as Leslie said in the NWR presentation over 40 patients have been dosed in the MAST trial.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)